Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Norepinephrine transporter | Starlite/ChEMBL | References |
Rattus norvegicus | Serotonin transporter | Starlite/ChEMBL | References |
Rattus norvegicus | Dopamine transporter | Starlite/ChEMBL | References |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
ED50 (functional) | ~ 24 mg kg-1 | Antagonism of tetrabenazine(TBZ)-induced depression measured in mice by motor activity | ChEMBL. | 3039136 |
ED50 (functional) | ~ 30 mg kg-1 | Antagonism of tetrabenazine(TBZ)-induced depression in mice measured for ptosis | ChEMBL. | 3039136 |
Ki (binding) | = 14.6 nM | Inhibition of uptake of tritiated norepinephrine(NE) in rat synaptosomes | ChEMBL. | 3039136 |
Ki (binding) | = 39.8 nM | Inhibition of the uptake of tritiated dopamine (DA) in rat synaptosomes | ChEMBL. | 3039136 |
Ki (binding) | = 43.3 nM | Inhibition the uptake of tritiated serotonin(5-HT)by the serotonin transporter SERT in rat synaptosomes | ChEMBL. | 3039136 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.